(Q38733242)

5 September 2017

title

Canine mesenchymal stem cells are neurotrophic and angiogenic: An in vitro assessment of their paracrine activity (English)

1 reference

5 September 2017

main subject

mesenchymal stem cell

1 reference

I R Al Delfi

1

1 reference

5 September 2017

J J Sheard

2

1 reference

5 September 2017

C R Wood

3

1 reference

5 September 2017

A Vernallis

4

1 reference

5 September 2017

J F Innes

5

1 reference

5 September 2017

P Myint

6

1 reference

5 September 2017

W E B Johnson

7

1 reference

5 September 2017

publication date

19 September 2016

1 reference

5 September 2017

published in

The Veterinary Journal

1 reference

5 September 2017

volume

217

1 reference

5 September 2017

page(s)

10-17

1 reference

Bone marrow transplants provide tissue protection and directional guidance for axons after contusive spinal cord injury in rats.

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Angiogenesis assays: a critical overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

The MSC: an injury drugstore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Gastrocnemius tendon strain in a dog treated with autologous mesenchymal stem cells and a custom orthosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Percutaneous transplantation of human umbilical cord-derived mesenchymal stem cells in a dog suspected to have fibrocartilaginous embolic myelopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Hip osteoarthritis in dogs: a randomized study using mesenchymal stem cells from adipose tissue and plasma rich in growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Extracellular matrix-regulated neural differentiation of human multipotent marrow progenitor cells enhances functional recovery after spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

A New Paradigm in Cardiac Regeneration: The Mesenchymal Stem Cell Secretome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Correction: Use of Autologous Human mesenchymal Stromal Cell/Fibrin Clot Constructs in Upper Limb Non-Unions: Long-Term Assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Autologous olfactory mucosal cell transplants in clinical spinal cord injury: a randomized double-blinded trial in a canine translational model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Mesenchymal stem cells for cartilage repair in osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Characterization of cells with osteogenic potential from human marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Concise review: Stem cell trials using companion animal disease models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Clinical canine spinal cord injury provides an opportunity to examine the issues in translating laboratory techniques into practical therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Designing clinical trials in canine spinal cord injury as a model to translate successful laboratory interventions into clinical practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Review of the adipose derived stem cell secretome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Transplantation of adipose derived mesenchymal stem cells for acute thoracolumbar disc disease with no deep pain perception in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Stimulating the neurotrophic and angiogenic properties of human adipose-derived stem cells enhances nerve repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

An In Vitro Comparison of the Incorporation, Growth, and Chondrogenic Potential of Human Bone Marrow versus Adipose Tissue Mesenchymal Stem Cells in Clinically Relevant Cell Scaffolds Used for Cartilage Repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Bone marrow stromal cells promote neurite outgrowth of spinal motor neurons by means of neurotrophic factors in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Characterization of conditioned medium of cultured bone marrow stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Molecular and cellular mechanisms underlying the role of blood vessels in spinal cord injury and repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Cytokine secretion profiling of human mesenchymal stem cells by antibody array.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Clinical and laboratory outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells for treatment of dogs with inflammatory bowel disease: Endoscopic and histological outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Use of autologous mesenchymal stem cells derived from bone marrow for the treatment of naturally injured spinal cord in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

The Secretome of Bone Marrow and Wharton Jelly Derived Mesenchymal Stem Cells Induces Differentiation and Neurite Outgrowth in SH-SY5Y Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Multilineage potential of adult human mesenchymal stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Pilot study: bone marrow stem cells as a treatment for dogs with chronic spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Functional and structural comparison of cytokines in different species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Human adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Functional recovery after severe CNS trauma: current perspectives for cell therapy with bone marrow stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Isolation, characterization, and differentiation potential of canine adipose-derived stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Controlled, blinded force platform analysis of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells associated to PRGF-Endoret in osteoarthritic dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Assessment of the effect of intraarticular injection of autologous adipose-derived mesenchymal stem cells in osteoarthritic dogs using a double blinded force platform analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Bone marrow stromal cells stimulate neurite outgrowth over neural proteoglycans (CSPG), myelin associated glycoprotein and Nogo-A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

A comparison of high-content screening versus manual analysis to assay the effects of mesenchymal stem cell-conditioned medium on neurite outgrowth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Spinal motor neurite outgrowth over glial scar inhibitors is enhanced by coculture with bone marrow stromal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: enhance hematopoiesis after cord blood transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Adult autologous mesenchymal stem cells for the treatment of suspected non-infectious inflammatory diseases of the canine central nervous system: safety, feasibility and preliminary clinical findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

Bone marrow mesenchymal stem cells in a three-dimensional gelatin sponge scaffold attenuate inflammation, promote angiogenesis, and reduce cavity formation in experimental spinal cord injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2016.09.003

10.1016/J.TVJL.2016.09.003

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference